BRN Discussion Ongoing

miaeffect

Oat latte lover
🤦🏻‍♂️


View attachment 64524



Mercedes-Benz has decided to cancel its MB.EA Large electric vehicle platform, citing slower-than-expected sales of the EQE and EQS models. This move, reported by Handelsblatt, is aimed at saving billions in development costs as the company reevaluates its luxury car strategy.

Originally slated for a 2028 release, the MB.EA platform was intended to incorporate technologies showcased in the Vision EQXX concept, including ultra-long-range capabilities. However, with the cancellation of the platform, expectations for 750 miles on a single charge have been dashed.
Instead, Mercedes plans to redirect resources into further development of its EVA2 platform, currently utilized by the EQS and EQE models.

CEO Ola Källenius assures shareholders of the company's commitment to both electric and combustion-engined vehicles in the foreseeable future.
Mercedes-Benz aims to achieve a CO2-neutral new car fleet by 2039, with electric and plug-in hybrid vehicles projected to constitute up to 50% of new car sales in the second half of the decade.

The company emphasizes flexibility in catering to customer preferences, offering vehicles with fully electric drivetrains or electrified combustion engines into the 2030s.

View attachment 64525

German publication Handelsblatt reports the MB.EA Large platform – set to underpin replacements for the current EQE, EQE SUV, EQS and EQS SUV – has been scrapped.

It was reportedly set to debut in 2028.

----

Mercedes-Benz will reportedly continue development of the related MB.EA Medium platform, which will underpin the upcoming EQC and EQC SUV.

----

The MB.EA platform was intended to underpin electric follow-on versions of the current Mercedes-Benz EQE and EQS electric sedans and SUVs with a planned introduction in 2028.

----

Mercedes-Benz has not officially confirmed the decision.

----

Nothing to worry YET
 
  • Like
  • Fire
Reactions: 7 users
Couple more from Nanose




This is the original one we were aware off and awaiting approval



Nothing mentioning Akida, but they must be close to having something coming to market soon


With the DiaNose breath test, the healthcare system will have an innovative, cost-effective tool to identify liver disease earlier and provide timely specialist care to patients.

With the significant support of the EIC-Transition grant and our innovative approach, we expect to bring the first non-invasive, user-friendly, and widely-accessible MASH/cirrhosis test to the market
 
Last edited:
  • Like
  • Fire
  • Thinking
Reactions: 13 users

Tothemoon24

Top 20

IMG_9061.jpeg



Shift in Reliance​

Image
Josh Broline

Josh Broline
Sr. Director, Marketing and Applications, High Reliability Business Unit



Published: June 7, 2024
Ever since the end of the Space Shuttle program in August of 2011, the United States has been relying on Russia for transport to the International Space Station. NASA has been driving towards domestic capability ever since. Fast forward to 2024, we are now at the doorstep of having two options, which will be owned and operated by commercial companies.

Transportation, infrastructure, and sustainment of Low Earth Orbit space stations are pivoting to the private sector, where governments will start to take more of a back seat approach versus owning the whole process. This is visibly on display with regard to the transportation aspect of this ecosystem. With the dawn of two US-based transport capsules to support carrying cargo and astronauts up to the International Space Station, this is a significant example of the ongoing pivot.
The successful launch and docking of the Boeing Starliner atop a United Launch Alliance Atlas V rocket are significant accomplishments for Boeing and for the space industry, as a whole. The new era of Low Earth Orbit sustained infrastructure is in full force with this accomplishment. With both commercial options transitioning into a normal flow of activity, it appears that NASA will have the ability to focus on other programs and support the handoff of the next-generation space station work to private industry. This certainly will take some time but will be exciting to watch how things unfold.
Image
Starliner spaceship in space. Expedition to the International Space Station.

Figure 1. Starliner spaceship in space. Expedition to the International Space Station.
Renesas high reliability space products, formerly owned by Intersil, have been supporting the space industry for six decades. From defense to commercial and space exploration, we have been a part of and witnessed it all. As the space industry pivots to significantly more utilization of Low Earth Orbit, we are working to position ourselves with the right products for the right mission profiles. Whether it is for short flight durations and lower radiation requirements, or long flight durations and high radiation requirements, our space grade products are meeting this ever-expanding spectrum of needs.
Our multi-production flow development strategy offers products in three different flows: Radiation Tolerant Plastic, Radiation Hardened Plastic, and Radiation Hardened Hermetic, which allows system designers to easily scale their designs based on program needs and get to market faster. Our broad portfolio of power management products covers a wide expanse from integrated FET regulators, PWM controllers, FET drivers (MOSFET and GaN FETs), GaN FETs, to linear regulators and power peripherals. This allows for compact, robust, and efficient power conversion from the solar panels down to the point of loads. Power management is like the heart of electrical systems, energizing the other parts of the system to do what they were designed to do.
Another core competency for the Renesas high reliability product portfolio has been the precision analog and mixed-signal product offerings. To support the evolving space landscape, a diverse array of products support precision sensor signal processing, everything from sensors all the way to the FPGAs/MPUs/MCUs with advancements in performance. Example products in this area are cold sparable multiplexors, precision operational amplifiers (op amps), precision voltage references, and high-resolution/precision analog-to-digital converters (ADCs). This portfolio of products is particularly well suited for telemetry, tracking, and control (TT&C) applications, but finds a home in most onboard payloads. Like the five senses of the human body working with our nervous system and brain to keep us out of trouble, these systems are responsible for maintaining the health and performance of the spacecraft. Like the five senses of the human body working with our nervous system and brain to keep us out of trouble, for example.
These space-grade solutions in the power management and sensor signal processing area, have considerable flight heritage and are available in both radiation hardened and radiation tolerant product flows, supporting different quality, reliability, performance, and cost points.
The Starliner is yet another great example of the paradigm shift that is ongoing in the space economy ecosystem. All facets of this ecosystem should, and are taking notice, evaluating technological advancements/needs and business models. This ultimately will enable an acceleration of maximizing space in endless dimensions.
 
  • Like
  • Thinking
  • Fire
Reactions: 13 users

German publication Handelsblatt reports the MB.EA Large platform – set to underpin replacements for the current EQE, EQE SUV, EQS and EQS SUV – has been scrapped.

It was reportedly set to debut in 2028.

----

Mercedes-Benz will reportedly continue development of the related MB.EA Medium platform, which will underpin the upcoming EQC and EQC SUV.

----

The MB.EA platform was intended to underpin electric follow-on versions of the current Mercedes-Benz EQE and EQS electric sedans and SUVs with a planned introduction in 2028.

----

Mercedes-Benz has not officially confirmed the decision.

----

Nothing to worry YET
There is nothing to see here . In fact there has been nothing to see for over 2 years . Nothing to read either . All wishful thinking and endless prattling. I cannot remember even hearing any crickets .Those models that they have produced prototypes of , were not to be introduced to the market for another 3 years . More important tasks at hand than urinating against the wind. Esq111 may offer his list of connections that we have , so as to remind us of the plethora of companies that we have connections with that , like that car company, may or may not move forward with their business plans to go into production. I remember an old and trusted poster here stating that he believed that Brainchip was at the tipping point and saw no reason for him to continue posting here anymore. I want a new Apple iPhone with us in it . Apple needs us for them to catch up with the AI revolution.
 
Last edited:
  • Like
  • Fire
  • Love
Reactions: 24 users

View attachment 64530


Shift in Reliance​

Image
Josh Broline

Josh Broline
Sr. Director, Marketing and Applications, High Reliability Business Unit



Published: June 7, 2024
Ever since the end of the Space Shuttle program in August of 2011, the United States has been relying on Russia for transport to the International Space Station. NASA has been driving towards domestic capability ever since. Fast forward to 2024, we are now at the doorstep of having two options, which will be owned and operated by commercial companies.

Transportation, infrastructure, and sustainment of Low Earth Orbit space stations are pivoting to the private sector, where governments will start to take more of a back seat approach versus owning the whole process. This is visibly on display with regard to the transportation aspect of this ecosystem. With the dawn of two US-based transport capsules to support carrying cargo and astronauts up to the International Space Station, this is a significant example of the ongoing pivot.
The successful launch and docking of the Boeing Starliner atop a United Launch Alliance Atlas V rocket are significant accomplishments for Boeing and for the space industry, as a whole. The new era of Low Earth Orbit sustained infrastructure is in full force with this accomplishment. With both commercial options transitioning into a normal flow of activity, it appears that NASA will have the ability to focus on other programs and support the handoff of the next-generation space station work to private industry. This certainly will take some time but will be exciting to watch how things unfold.
Image
Starliner spaceship in space. Expedition to the International Space Station.

Figure 1. Starliner spaceship in space. Expedition to the International Space Station.
Renesas high reliability space products, formerly owned by Intersil, have been supporting the space industry for six decades. From defense to commercial and space exploration, we have been a part of and witnessed it all. As the space industry pivots to significantly more utilization of Low Earth Orbit, we are working to position ourselves with the right products for the right mission profiles. Whether it is for short flight durations and lower radiation requirements, or long flight durations and high radiation requirements, our space grade products are meeting this ever-expanding spectrum of needs.
Our multi-production flow development strategy offers products in three different flows: Radiation Tolerant Plastic, Radiation Hardened Plastic, and Radiation Hardened Hermetic, which allows system designers to easily scale their designs based on program needs and get to market faster. Our broad portfolio of power management products covers a wide expanse from integrated FET regulators, PWM controllers, FET drivers (MOSFET and GaN FETs), GaN FETs, to linear regulators and power peripherals. This allows for compact, robust, and efficient power conversion from the solar panels down to the point of loads. Power management is like the heart of electrical systems, energizing the other parts of the system to do what they were designed to do.
Another core competency for the Renesas high reliability product portfolio has been the precision analog and mixed-signal product offerings. To support the evolving space landscape, a diverse array of products support precision sensor signal processing, everything from sensors all the way to the FPGAs/MPUs/MCUs with advancements in performance. Example products in this area are cold sparable multiplexors, precision operational amplifiers (op amps), precision voltage references, and high-resolution/precision analog-to-digital converters (ADCs). This portfolio of products is particularly well suited for telemetry, tracking, and control (TT&C) applications, but finds a home in most onboard payloads. Like the five senses of the human body working with our nervous system and brain to keep us out of trouble, these systems are responsible for maintaining the health and performance of the spacecraft. Like the five senses of the human body working with our nervous system and brain to keep us out of trouble, for example.
These space-grade solutions in the power management and sensor signal processing area, have considerable flight heritage and are available in both radiation hardened and radiation tolerant product flows, supporting different quality, reliability, performance, and cost points.
The Starliner is yet another great example of the paradigm shift that is ongoing in the space economy ecosystem. All facets of this ecosystem should, and are taking notice, evaluating technological advancements/needs and business models. This ultimately will enable an acceleration of maximizing space in endless dimensions.
When I saw the words "Boeing Starliner" I thought Wow, what's that??

20240609_143139.jpg


Is it just me, or did they just whack a new paint job, on the old Apollo 11 command module and call it done?

20240609_143049.jpg
 
  • Haha
  • Like
Reactions: 9 users

Diogenese

Top 20
  • Haha
  • Like
  • Love
Reactions: 29 users
  • Like
  • Love
Reactions: 4 users
Nice to see Tata Elxsi still on the neuromorphic train.



MULTIMODAL AI AND NEUROMORPHIC AI: DETECTION, DIAGNOSIS, PROGNOSIS

Navigate​


The synergy of cutting-edge technologies like Multimodal and Neuromorphic AI signals a pivotal shift from reactive to proactive healthcare. This article explores captivating use cases, offering insights on the implementation of Responsible AI.
Join us as we navigate the frontier of healthcare, where the synergy of innovation and responsibility promises a revolution in patient care and well-being.

Current state of AI adoption in Healthcare​

Unlocking the full potential of AI in healthcare is an uncharted journey. From optimising drug combinations to spearheading clinical correlation and toxicity studies, AI is set to redefine every facet of the industry. Despite its transformative capabilities, AI remains a niche technology, requiring a nuanced understanding of its application in healthcare.

The tides are changing as the healthcare sector recognises the urgency for an interdisciplinary approach, marrying engineering with medical science. This paradigm shift signals an imminent era where AI’s vast capabilities will revolutionise diagnostics, patient treatment, protocols, drug development and delivery, and prescription practices over the next decade.

Join us as we navigate the frontier of healthcare, where the synergy of innovation and responsibility promises a revolution in patient care and well-being.

Multimodal AI and Neuromorphic Technology – A new era in Preventive Healthcare​

In the ever-evolving landscape of healthcare, the amalgamation of Multimodal AI and Neuromorphic Technology marks a pivotal moment—a shift from reactive medicine to a proactive, preventive healthcare paradigm. This synergy is not just a collaboration of cutting-edge technologies; it’s a gateway to a future where wellness takes centre stage.
Multimodal AI and Neuromorphic Technology A new era in Preventive Healthcare

These technologies hold promise to transform healthcare by enhancing diagnostics, enabling personalised medicine, predicting long-term prognosis and contributing to innovations in therapeutic interventions.

Let’s delve into compelling use cases and glimpse the future of preventive healthcare.

The tides are changing as the healthcare sector recognises the urgency for an interdisciplinary approach, marrying engineering with medical science. This paradigm shift signals an imminent era where AI’s vast capabilities will revolutionise diagnostics, patient treatment, protocols, drug development and delivery, and prescription practices over the next decade.

Join us as we navigate the frontier of healthcare, where the synergy of innovation and responsibility promises a revolution in patient care and well-being.

Defining Multimodal and Neuromorphic AI​

Multi-modal AI​

Multimodal AI refers to the artificial intelligence systems that process and analyse data from multiple modalities or sources. In healthcare, these modalities often include both visual and clinical data. Visual data may include medical images from scans, while clinical data encompasses patient records, parameters, and test reports. Multimodal AI integrates these diverse data types to provide a comprehensive understanding, draw meaningful insights and give suggestions based on data and image analytics.

Neuromorphic Technology​

The term “neuromorphic” comes from the combination of “neuro” (related to the nervous system) and “morphic” (related to form or structure). Neuromorphic technology is an innovative approach in computing that draws inspiration from the structure and function of a human brain. These are AI powered by brain-like computing architectures. It can help process larger amount of data with less computing power, memory and electric power consumption. Neuromorphic Technology utilises Artificial Neural Networks (ANN) and Spiking Neural Networks (SNN) to mimic the parallel processing, event-driven nature, and adaptability observed in biological brains.
Defining Multimodal and Neuromorphic AI

Multimodal Inputs​

  • Medical Images
  • Lab Reports
  • Clinical History
  • Patient Demographic Information

Fusion Module​

Cross-modal attention mechanism to dynamically weigh the importance of text, video, and other parameters for calculating index to decide priority of selection.

Inference Outputs​

Inference Results for
  • Diagnostic
  • Prognostic
  • Lifestyle Recommendation
  • Disease Prediction

Use Cases of Multimodal and Neuromorphic AI​

Early Screening & Disease Detection​

Multimodal AI​

  • Integrates visual and clinical data for holistic analysis.
  • Advanced –image recognition for early detection.
  • Comprehensive patient profiling.

Neuromorphic Technology​

  • Efficient pattern recognition for subtle disease indicators.
  • Event-driven processing for real-time detection. This is crucial for detecting anomalies or irregularities that may be early signs of diseases.
  • Continuous monitoring for dynamic changes. This continuous surveillance is especially valuable for conditions with varying symptoms.

Diagnosis​

Multimodal AI​

  • Integrated diagnostic insights from diverse data.
  • Cross-verification for reliability.
  • Tailored treatment plans based on nuanced understanding.
  • Continuous updates based on latest findings reported in the subject.

Neuromorphic Technology​

  • Large and Efficient data processing with minimal energy consumption. This efficiency contributes to faster and more accurate diagnoses.
  • Allows integration of more complex algorithms on wearable devices; makes diagnostics more real-time and helps timely interventions
  • Implantable devices can be made AI enabled with Neuromorphic computing, due to the low computing requirement and power consumption, making the diagnosis and management more precise and real-time.
  • Adaptive intelligence for dynamic adjustments. This adaptability enhances the precision of diagnostic processes. This event-driven processing aligns with the dynamic nature of healthcare data allowing for more accurate and timely diagnoses.
  • SNN for real-time response
    and accuracy.

Prognosis​

Multimodal AI​

  • Research Advancements: Facilitates discovery of new insights, contributing to medical advancements and innovations.
  • Personalised Prognostic Models: Considering both visual and clinical data, these models account for individual variations, and correlate with prior case records and provide more accurate predictions of disease outcomes.
  • Dynamic Adaptability: The adaptability of multimodal AI to changing data patterns ensures that prognostic models can dynamically adjust based on evolving patient conditions and improve prognosis predictions

Neuromorphic Technology​

  • Analysis of longitudinal data for predicting disease progression.
  • Dynamic adaptability in prognostic models that can adjust to changing data patterns. This adaptability improves prognosis prediction accuracy for evolving patient conditions.
  • Personalised prognostic insights based on individual variations can help in more accurate predictions tailored to individual patient profiles.

Tata Elxsi Use Case​

Disease Detection and Diagnosis​

Utilising Neuromorphic Technology, we’ve achieved significant advancements in the analysis of medical images on low-computing embedded platforms, enabling on-field diagnostics of ultrasound images.

This innovative approach provides critical diagnostic information for musculoskeletal injuries, including tissue damage extent, recovery progress, and healing time predictions, all with enhanced efficiency and device portability making it ideal for applications such as sports medicine.

Applications of Multimodal and Neuromorphic AI​

Multimodal AI​

  • Comprehensive Patient Analysis
  • Diagnostic Accuracy
  • Mental Health and Behavioural Analysis
  • Lifestyle Reviews and Recommendations
  • Management of Chronic Diseases like Diabetes/HT/Cardiac Diseases with continous monitoring and personalised medications
  • Diagnosis/Management and Prognosis of various types of cancers, Digital Drug Trials, Effective Pandemic Surveillance and staging, Gene Therapy and Genomics
  • Recommendations for interventions and Prioritisation of therapeutic resources and modalities

Neuromorphic Technology​

  • Implants, Wearables Devices
  • Processing Large Data
  • Medical Imaging Analysis
  • Drug Discovery and Personalised Medicine
  • Robotic Surgery Assistance
  • Neurological Disorder Understanding
  • Patient Care and Rehabilitation
  • Predictive Analytics for Healthcare Management
  • Energy Efficient Remote Monitoring

The Synergy of MLOps and Advanced AI​

The transformative impact of MLOps across operational efficiency, data management, patient outcomes, and the overall quality of care is unmistakable. In the quest for advancing healthcare, the convergence of Machine Learning Operations (MLOps) with Multimodal and Neuromorphic AI has emerged as a game-changer. These technologies can help in seamless deployment, continuous monitoring, and collaborative development across various stakeholders in the healthcare ecosystem.

While Advanced AI Technologies offer the potential for improvising the use cases, the application of MLOps can be instrumental in strengthening and regulating these advancements. It achieves this by bringing in streamlined AI development processes, dataset management, continuous monitoring of model accuracy across different versions, ensuring the deployment of thoroughly vetted versions for clinical use.

Additonally, MLOps frameworks enable and learn from deviations, further enhancing their efficacy in healthcare applications.

Use Cases​


Disease Detection​

Disease Prediction and Prevention
Real World Application – Early Detection of Chronic Disease, Infectious Disease Monitoring
Healthcare Fraud Detection
Real World Application – Claims Analysis, Identify Theft Prevention
Medical Imaging Analysis
Real World Application – Early Cancer Detection, Neurological Disorders Diagnosis
Genomic Research
Real World Application – Cancer Genomics, Rare Genetic Diseases

Diagnosis​

Drug Discovery and Development
Real World Application – Protein Folding Prediction, Drug Toxicity Prediction
Personalised Medicine
Real World Application – Oncology and Targeted Therapies, Chronic Disease Management
Healthcare Resource Management
Real World Application – Emergency Room Digitalised Management, Pharmaceutical Supply Chain Management

Prognosis​

Prediction of Clinical Outcome
Real World Application – Prediction of recovery time and quality of life, Adverse Effects, Short term and long term impact
Remote Patient Monitoring
Real World Application – Chronic Disease Management, Post Surgery Monitoring

Responsible AI – Navigating Ethical Frontiers​

In the realm of AI, addressing bias stands as a pivotal ethical imperative, particularly in fields like medical analysis where the demand for precision is ethically, legally, and morally paramount. As AI practitioners, our commitment to responsible AI requires rigorous testing using diverse, unbiased anonymised datasets, continual monitoring to mitigate biases, and a steadfast dedication to achieving fair outcomes across diverse patient populations.
Ethical AI

Moreover, the ethical considerations extend to the strategic utilisation of data. The foundation of responsible AI in healthcare is laid upon a robust ethical framework that guides the entire lifecycle of Neuromorphic and Multimodal AI systems. Stakeholders must unwaveringly adhere to established ethical principles, ensuring transparency, fairness, and accountability at every stage of AI implementation.

When we delve into the realm of Gen AI, the potential for malpractice looms. Consider scenarios where a patient, with normal renal function manageable through medication, undergoes a renal scan. Unscrupulous use of Gen AI could manipulate images, creating false lesions, leading to unnecessary surgeries or even nephrectomy which can benefit illegal organ trade

Thus, the imperative lies in defining strong ethical boundaries, implementing robust audits, and establishing legal frameworks to prevent data manipulation and ensure the highest standards of integrity.

In embracing these technological advancements responsibly, we are not just witnessing the future of healthcare; we are actively shaping it. The era of proactive, preventive healthcare beckons, promising a future where wellness is at the forefront of the industry’s evolution.

The shift from traditional, one-size-fits-all medical practices, prone to misinterpretation and diagnostic errors, to AI-enhanced methodologies, heralds a new era of precision and personalised care. AI’s capability to analyse a broad spectrum of patient data—ranging from genetic backgrounds to lifestyle factors—promises a departure from misdiagnoses and introduces tailored therapeutic interventions.

AI and multimodal technologies enable a holistic view of the patient’s health, integrating diverse data points. While, Neuromorphic computing advances the portability of medical devices, including wearables and implants, transforming them into intelligent systems capable of adapting to varying conditions.

As thought leaders in the healthcare industry, our commitment to responsibly integrate these technologies paves the way for a future where healthcare is not only reactive, but anticipatory, personalised, and universally accessible.

Author
Anup SS, Practice Head, AI and ML, Tata Elxsi
Anup S S
Practice Head, Artificial Intelligence, Tata Elxsi
Anup S.S. is a visionary in leveraging Artificial Intelligence, Machine Learning and Deep Learning. Leading breakthrough AI projects in healthcare, Anup’s strategic insight and innovation ignite client success, unlocking AI’s full potential.

Book Your Exclusive Print Copy Now!​


© 2024 TATA ELXSI
PRIVACY POLICY
COOKIE POLICY
TERMS OF USE
Facebook Twitter Youtube Linkedin Instagram Envelope
 
  • Like
  • Fire
  • Love
Reactions: 45 users
Nice to see Tata Elxsi still on the neuromorphic train.



MULTIMODAL AI AND NEUROMORPHIC AI: DETECTION, DIAGNOSIS, PROGNOSIS

Navigate​


The synergy of cutting-edge technologies like Multimodal and Neuromorphic AI signals a pivotal shift from reactive to proactive healthcare. This article explores captivating use cases, offering insights on the implementation of Responsible AI.
Join us as we navigate the frontier of healthcare, where the synergy of innovation and responsibility promises a revolution in patient care and well-being.

Current state of AI adoption in Healthcare​

Unlocking the full potential of AI in healthcare is an uncharted journey. From optimising drug combinations to spearheading clinical correlation and toxicity studies, AI is set to redefine every facet of the industry. Despite its transformative capabilities, AI remains a niche technology, requiring a nuanced understanding of its application in healthcare.

The tides are changing as the healthcare sector recognises the urgency for an interdisciplinary approach, marrying engineering with medical science. This paradigm shift signals an imminent era where AI’s vast capabilities will revolutionise diagnostics, patient treatment, protocols, drug development and delivery, and prescription practices over the next decade.

Join us as we navigate the frontier of healthcare, where the synergy of innovation and responsibility promises a revolution in patient care and well-being.

Multimodal AI and Neuromorphic Technology – A new era in Preventive Healthcare​

In the ever-evolving landscape of healthcare, the amalgamation of Multimodal AI and Neuromorphic Technology marks a pivotal moment—a shift from reactive medicine to a proactive, preventive healthcare paradigm. This synergy is not just a collaboration of cutting-edge technologies; it’s a gateway to a future where wellness takes centre stage.
Multimodal AI and Neuromorphic Technology A new era in Preventive Healthcare

These technologies hold promise to transform healthcare by enhancing diagnostics, enabling personalised medicine, predicting long-term prognosis and contributing to innovations in therapeutic interventions.

Let’s delve into compelling use cases and glimpse the future of preventive healthcare.

The tides are changing as the healthcare sector recognises the urgency for an interdisciplinary approach, marrying engineering with medical science. This paradigm shift signals an imminent era where AI’s vast capabilities will revolutionise diagnostics, patient treatment, protocols, drug development and delivery, and prescription practices over the next decade.

Join us as we navigate the frontier of healthcare, where the synergy of innovation and responsibility promises a revolution in patient care and well-being.

Defining Multimodal and Neuromorphic AI​

Multi-modal AI​

Multimodal AI refers to the artificial intelligence systems that process and analyse data from multiple modalities or sources. In healthcare, these modalities often include both visual and clinical data. Visual data may include medical images from scans, while clinical data encompasses patient records, parameters, and test reports. Multimodal AI integrates these diverse data types to provide a comprehensive understanding, draw meaningful insights and give suggestions based on data and image analytics.

Neuromorphic Technology​

The term “neuromorphic” comes from the combination of “neuro” (related to the nervous system) and “morphic” (related to form or structure). Neuromorphic technology is an innovative approach in computing that draws inspiration from the structure and function of a human brain. These are AI powered by brain-like computing architectures. It can help process larger amount of data with less computing power, memory and electric power consumption. Neuromorphic Technology utilises Artificial Neural Networks (ANN) and Spiking Neural Networks (SNN) to mimic the parallel processing, event-driven nature, and adaptability observed in biological brains.
Defining Multimodal and Neuromorphic AI

Multimodal Inputs​

  • Medical Images
  • Lab Reports
  • Clinical History
  • Patient Demographic Information

Fusion Module​

Cross-modal attention mechanism to dynamically weigh the importance of text, video, and other parameters for calculating index to decide priority of selection.

Inference Outputs​

Inference Results for
  • Diagnostic
  • Prognostic
  • Lifestyle Recommendation
  • Disease Prediction

Use Cases of Multimodal and Neuromorphic AI​

Early Screening & Disease Detection​

Multimodal AI​

  • Integrates visual and clinical data for holistic analysis.
  • Advanced –image recognition for early detection.
  • Comprehensive patient profiling.

Neuromorphic Technology​

  • Efficient pattern recognition for subtle disease indicators.
  • Event-driven processing for real-time detection. This is crucial for detecting anomalies or irregularities that may be early signs of diseases.
  • Continuous monitoring for dynamic changes. This continuous surveillance is especially valuable for conditions with varying symptoms.

Diagnosis​

Multimodal AI​

  • Integrated diagnostic insights from diverse data.
  • Cross-verification for reliability.
  • Tailored treatment plans based on nuanced understanding.
  • Continuous updates based on latest findings reported in the subject.

Neuromorphic Technology​

  • Large and Efficient data processing with minimal energy consumption. This efficiency contributes to faster and more accurate diagnoses.
  • Allows integration of more complex algorithms on wearable devices; makes diagnostics more real-time and helps timely interventions
  • Implantable devices can be made AI enabled with Neuromorphic computing, due to the low computing requirement and power consumption, making the diagnosis and management more precise and real-time.
  • Adaptive intelligence for dynamic adjustments. This adaptability enhances the precision of diagnostic processes. This event-driven processing aligns with the dynamic nature of healthcare data allowing for more accurate and timely diagnoses.
  • SNN for real-time response
    and accuracy.

Prognosis​

Multimodal AI​

  • Research Advancements: Facilitates discovery of new insights, contributing to medical advancements and innovations.
  • Personalised Prognostic Models: Considering both visual and clinical data, these models account for individual variations, and correlate with prior case records and provide more accurate predictions of disease outcomes.
  • Dynamic Adaptability: The adaptability of multimodal AI to changing data patterns ensures that prognostic models can dynamically adjust based on evolving patient conditions and improve prognosis predictions

Neuromorphic Technology​

  • Analysis of longitudinal data for predicting disease progression.
  • Dynamic adaptability in prognostic models that can adjust to changing data patterns. This adaptability improves prognosis prediction accuracy for evolving patient conditions.
  • Personalised prognostic insights based on individual variations can help in more accurate predictions tailored to individual patient profiles.

Tata Elxsi Use Case​

Disease Detection and Diagnosis​

Utilising Neuromorphic Technology, we’ve achieved significant advancements in the analysis of medical images on low-computing embedded platforms, enabling on-field diagnostics of ultrasound images.

This innovative approach provides critical diagnostic information for musculoskeletal injuries, including tissue damage extent, recovery progress, and healing time predictions, all with enhanced efficiency and device portability making it ideal for applications such as sports medicine.

Applications of Multimodal and Neuromorphic AI​

Multimodal AI​

  • Comprehensive Patient Analysis
  • Diagnostic Accuracy
  • Mental Health and Behavioural Analysis
  • Lifestyle Reviews and Recommendations
  • Management of Chronic Diseases like Diabetes/HT/Cardiac Diseases with continous monitoring and personalised medications
  • Diagnosis/Management and Prognosis of various types of cancers, Digital Drug Trials, Effective Pandemic Surveillance and staging, Gene Therapy and Genomics
  • Recommendations for interventions and Prioritisation of therapeutic resources and modalities

Neuromorphic Technology​

  • Implants, Wearables Devices
  • Processing Large Data
  • Medical Imaging Analysis
  • Drug Discovery and Personalised Medicine
  • Robotic Surgery Assistance
  • Neurological Disorder Understanding
  • Patient Care and Rehabilitation
  • Predictive Analytics for Healthcare Management
  • Energy Efficient Remote Monitoring

The Synergy of MLOps and Advanced AI​

The transformative impact of MLOps across operational efficiency, data management, patient outcomes, and the overall quality of care is unmistakable. In the quest for advancing healthcare, the convergence of Machine Learning Operations (MLOps) with Multimodal and Neuromorphic AI has emerged as a game-changer. These technologies can help in seamless deployment, continuous monitoring, and collaborative development across various stakeholders in the healthcare ecosystem.

While Advanced AI Technologies offer the potential for improvising the use cases, the application of MLOps can be instrumental in strengthening and regulating these advancements. It achieves this by bringing in streamlined AI development processes, dataset management, continuous monitoring of model accuracy across different versions, ensuring the deployment of thoroughly vetted versions for clinical use.

Additonally, MLOps frameworks enable and learn from deviations, further enhancing their efficacy in healthcare applications.

Use Cases​


Disease Detection​

Disease Prediction and Prevention
Real World Application – Early Detection of Chronic Disease, Infectious Disease Monitoring
Healthcare Fraud Detection
Real World Application – Claims Analysis, Identify Theft Prevention
Medical Imaging Analysis
Real World Application – Early Cancer Detection, Neurological Disorders Diagnosis
Genomic Research
Real World Application – Cancer Genomics, Rare Genetic Diseases

Diagnosis​

Drug Discovery and Development
Real World Application – Protein Folding Prediction, Drug Toxicity Prediction
Personalised Medicine
Real World Application – Oncology and Targeted Therapies, Chronic Disease Management
Healthcare Resource Management
Real World Application – Emergency Room Digitalised Management, Pharmaceutical Supply Chain Management

Prognosis​

Prediction of Clinical Outcome
Real World Application – Prediction of recovery time and quality of life, Adverse Effects, Short term and long term impact
Remote Patient Monitoring
Real World Application – Chronic Disease Management, Post Surgery Monitoring

Responsible AI – Navigating Ethical Frontiers​

In the realm of AI, addressing bias stands as a pivotal ethical imperative, particularly in fields like medical analysis where the demand for precision is ethically, legally, and morally paramount. As AI practitioners, our commitment to responsible AI requires rigorous testing using diverse, unbiased anonymised datasets, continual monitoring to mitigate biases, and a steadfast dedication to achieving fair outcomes across diverse patient populations.
Ethical AI

Moreover, the ethical considerations extend to the strategic utilisation of data. The foundation of responsible AI in healthcare is laid upon a robust ethical framework that guides the entire lifecycle of Neuromorphic and Multimodal AI systems. Stakeholders must unwaveringly adhere to established ethical principles, ensuring transparency, fairness, and accountability at every stage of AI implementation.

When we delve into the realm of Gen AI, the potential for malpractice looms. Consider scenarios where a patient, with normal renal function manageable through medication, undergoes a renal scan. Unscrupulous use of Gen AI could manipulate images, creating false lesions, leading to unnecessary surgeries or even nephrectomy which can benefit illegal organ trade

Thus, the imperative lies in defining strong ethical boundaries, implementing robust audits, and establishing legal frameworks to prevent data manipulation and ensure the highest standards of integrity.

In embracing these technological advancements responsibly, we are not just witnessing the future of healthcare; we are actively shaping it. The era of proactive, preventive healthcare beckons, promising a future where wellness is at the forefront of the industry’s evolution.

The shift from traditional, one-size-fits-all medical practices, prone to misinterpretation and diagnostic errors, to AI-enhanced methodologies, heralds a new era of precision and personalised care. AI’s capability to analyse a broad spectrum of patient data—ranging from genetic backgrounds to lifestyle factors—promises a departure from misdiagnoses and introduces tailored therapeutic interventions.

AI and multimodal technologies enable a holistic view of the patient’s health, integrating diverse data points. While, Neuromorphic computing advances the portability of medical devices, including wearables and implants, transforming them into intelligent systems capable of adapting to varying conditions.

As thought leaders in the healthcare industry, our commitment to responsibly integrate these technologies paves the way for a future where healthcare is not only reactive, but anticipatory, personalised, and universally accessible.

Author
Anup SS, Practice Head, AI and ML, Tata Elxsi
Anup S S
Practice Head, Artificial Intelligence, Tata Elxsi
Anup S.S. is a visionary in leveraging Artificial Intelligence, Machine Learning and Deep Learning. Leading breakthrough AI projects in healthcare, Anup’s strategic insight and innovation ignite client success, unlocking AI’s full potential.

Book Your Exclusive Print Copy Now!​


© 2024 TATA ELXSI
PRIVACY POLICY
COOKIE POLICY
TERMS OF USE
Facebook Twitter Youtube Linkedin Instagram Envelope
Great read FMF.

Oh wow, if this ends up being the Brainchip train, then buckle up because this could become one hell of a ride!
 
  • Like
  • Fire
  • Love
Reactions: 36 users
It would be really nice, to get a partnership going with Nvidia..

They seem to be doing everything right at the moment.

This is a good video, if people have the Time to watch it..



Humanoid robots, are going to be a massive market, from 2025 onwards.

Car manufacturing, is a dying market and not a growth market, in my opinion.
It's been fraught with struggles, for many years, as can be seen with so much consolidation, over the last 40..

Even something as iconic as a Lamborghini, is just a fast VW with a badge.
Your luxurious Audi, is the same..
Hitler's Revenge (my Father's nickname for the VW fastback I learned to drive in) with fast glass.

Less and less people, will own or drive cars in the Future, even now, how many 5 seater cars, are driving around, with just one person in them?
With technology for business/entertainment and service industries, there are even less reasons to drive or own a car, let alone buy a new one, which quickly depreciates in value.

But humanoid robots, is a fresh new market.
Although incredibly complex, I think they are a much simpler to manufacture proposition, when supply chains and all the interconnected systems and features of an automobile are taken into consideration.

Elon Musk sees this and it's why he knows Optimus, will make Tesla a far greater and more successful Company, than by making EVs.

Hyundai owns Boston Dynamics, who are developing the new Atlas.

I can see companies like VW Group, Daimler AG, GM, Ford, Toyota etc also moving in this direction.
Not totally abandoning cars, but taking advantage of a fresh new and more profitable market.


Of course A.I. is the backbone of all this development and what's going to make it all "work".

Neuromorphic A.I. has an incredibly strong Future, in this field.

Hmm maybe just 5 more years 🤔...
But the Foundation stones, will be laid "Tomorrow".
 
Last edited:
  • Like
  • Fire
Reactions: 12 users

goodvibes

Regular

Neuromorphic Computing. “Brain on a chip”​


Brainchip got a mention….In addition to these tech behemoths, several startups are making waves in neuromorphic computing. BrainChip, for instance, has developed the Akida Neuromorphic System-on-Chip, which brings AI to the edge in a way that existing technologies are incapable of. The Akida chip is designed to provide a complete ultra-low-power AI Edge Network for vision, audio, olfactory, and innovative transducer applications (BrainChip, 2020).

 
  • Like
  • Love
  • Fire
Reactions: 34 users

Terroni2105

Founding Member
Just a reminder Chippers, the ASX is closed tomorrow for a public holiday so there will be no trading
 
  • Like
  • Sad
  • Wow
Reactions: 16 users

Guzzi62

Regular

Final thoughts on key topics​


Let’s close on some of the key issues we haven’t hit.

Breaking-Analysis_-How-NVIDIA-TSM-Broadcom-and-Qualcomm-Will-Lead-a-Trillion-Dollar-Silicon-Boom-6-1024x576.jpg

The future of AI and its market dynamics are evolving rapidly, with significant implications for key players and emerging technologies. Our analysis highlights the pivotal trends and forecasts that will shape the AI landscape over the next decade, focusing on AI inference at the edge, energy needs, geopolitical risks and the potential shifts in semiconductor manufacturing.

Key points​

  • AI inference at the edge:
    • By 2034, 80% of AI spending is projected to be on inference at the edge.
    • This workload is expected to dominate the AI market.
    • While Nvidia currently holds a strong position in AI inference, driven largely by ChatGPT, the competitive landscape for high-volume, low-cost, low-power inference at the edge remains wide open and will challenge Nvidia’s dominance.
 
  • Like
  • Fire
  • Thinking
Reactions: 6 users

Final thoughts on key topics​


Let’s close on some of the key issues we haven’t hit.

Breaking-Analysis_-How-NVIDIA-TSM-Broadcom-and-Qualcomm-Will-Lead-a-Trillion-Dollar-Silicon-Boom-6-1024x576.jpg

The future of AI and its market dynamics are evolving rapidly, with significant implications for key players and emerging technologies. Our analysis highlights the pivotal trends and forecasts that will shape the AI landscape over the next decade, focusing on AI inference at the edge, energy needs, geopolitical risks and the potential shifts in semiconductor manufacturing.

Key points​

  • AI inference at the edge:
    • By 2034, 80% of AI spending is projected to be on inference at the edge.
    • This workload is expected to dominate the AI market.
    • While Nvidia currently holds a strong position in AI inference, driven largely by ChatGPT, the competitive landscape for high-volume, low-cost, low-power inference at the edge remains wide open and will challenge Nvidia’s dominance.
20240609_181637.jpg



There's a joke there somewhere, I'm sure 🤔..
 
  • Haha
  • Thinking
  • Like
Reactions: 4 users

Diogenese

Top 20

View attachment 64580
I thought Todd could have done better when the interviewer was pushing for details of how it works.

He should have explained the difference between neuron spikes which add up to a threshold value and fire a spike, as compared to mathematical MACs.

Onsemi airbag deployment gets a mention.

 
  • Like
  • Fire
  • Love
Reactions: 15 users

Labsy

Regular
We can only hope that one of Sean important meetings was with Apples AI main man Mr John Giannandrea....This would be insane.

 
  • Like
  • Fire
  • Wow
Reactions: 22 users
Top Bottom